Steatorrhea causes
Steatorrhea Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Steatorrhea causes On the Web |
American Roentgen Ray Society Images of Steatorrhea causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
Steatorrhea may be caused by Celiac disease, choledocholithiasis, cystic fibrosis, exocrine pancreatic insufficiency, hypolipidemic drugs, inflammatory bowel disease, small bowel bacterial overgrowth syndrome.
Causes
Common causes
Steatorrhea may be caused by.[1][2][3][4][5]
- Celiac disease
- Choledocholithiasis
- Cystic fibrosis
- Exocrine pancreatic insufficiency
- Hypolipidemic drugs
- Inflammatory bowel disease
- Small bowel bacterial overgrowth syndrome
Less Common causes
Less common causes of steatorrhea include:[6][7][8][9]
Causes by Organ System
Cardiovascular | No underlying causes |
Chemical/Poisoning | No underlying causes |
Dental | No underlying causes |
Dermatologic | No underlying causes |
Drug Side Effect | Hypolipidemic agent, Lanreotide, Octreotide. |
Ear Nose Throat | No underlying causes |
Endocrine | Graves' disease, Hyperthyroidism, |
Environmental | No underlying causes |
Gastroenterologic | Angiodysplasia, Bacterial overgrowth, Celiac disease, Cholecystectomy, Choledocholithiasis, Chronic atrophic gastritis, Chronic pancreatitis, Diverticulosis, Inflammatory bowel disease, Mesenteric ischemia, Post-gastrectomy, Post-vagotomy, Primary bile acid malabsorption , Primary sclerosing cholangitis, Radiation enteropathy, Short bowel syndrome, Strictures. |
Genetic | Abetalipoproteinemia, Cystic fibrosis , Diacylglycerol acyltransferase 1 deficiency, Johanson-blizzard syndrome , Pancreatic lipase deficiency, Pearson syndrome, Shwachman-Diamond syndrome. |
Hematologic | No underlying causes |
Iatrogenic | No underlying causes |
Infectious Disease | Fish tape worm, Giardiasis , HIV related malabsorption, Hookworm, Round worm, Tropical sprue, Whipple's disease |
Musculoskeletal/Orthopedic | No underlying causes |
Neurologic | No underlying causes |
Nutritional/Metabolic | No underlying causes |
Obstetric/Gynecologic | No underlying causes |
Oncologic | Colorectal cancer, Pancreatic cancer, Zollinger-Ellison syndrome. |
Ophthalmologic | No underlying causes |
Overdose/Toxicity | No underlying causes |
Psychiatric | No underlying causes |
Pulmonary | No underlying causes |
Renal/Electrolyte | No underlying causes |
Rheumatology/Immunology/Allergy | Systemic sclerosis |
Sexual | No underlying causes |
Trauma | No underlying causes |
Urologic | No underlying causes |
Miscellaneous | Natural fats (Butterfish, Escolar, Oilfish), Artificial fats (Olestra). |
Causes in Alphabetical Order
- Abetalipoproteinemia
- Angiodysplasia
- Artificial fats
- Bacterial overgrowth
- Cholecystectomy
- Choledocholithiasis
- Chronic atrophic gastritis
- Chronic pancreatitis
- Coeliac disease
- Cystic fibrosis
- Diacylglycerol acyltransferase 1 deficiency
- Diverticulosis
- Fish tape worm
- HIV related malabsorption
- Hookworm
- Giardiasis
- Graves' disease
- Hyperthyroidism
- Hypolipidemic agent
- Inflammatory bowel disease
- Johanson-blizzard syndrome
- Lanreotide
- Mesenteric ischemia
- Natural fats (Butterfish, Escolar, Oilfish)
- Octreotide
- Orlistat
- Pancreatic cancer
- Pancreatic lipase deficiency
- Pearson syndrome
- Post-gastrectomy
- Post-vagotomy
- Primary bile acid malabsorption
- Primary sclerosing cholangitis
- Radiation enteropathy
- Round worm
- Short bowel syndrome
- Shwachman-Diamond syndrome
- Strictures
- Systemic sclerosis
- Tropical sprue
- Whipple's disease
- Zollinger-Ellison syndrome
References
- ↑ Scarpignato C, Gatta L, Zullo A, Blandizzi C, SIF-AIGO-FIMMG Group. Italian Society of Pharmacology, the Italian Association of Hospital Gastroenterologists, and the Italian Federation of General Practitioners (2016). "Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression". BMC Med. 14 (1): 179. doi:10.1186/s12916-016-0718-z. PMC 5101793. PMID 27825371.
- ↑ Podboy A, Anderson BW, Sweetser S (2016). "61-Year-Old Man With Chronic Diarrhea". Mayo Clin Proc. 91 (2): e23–8. doi:10.1016/j.mayocp.2015.07.033. PMID 26769182.
- ↑ Burnett JR, Hooper AJ (2015). "Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia". Free Radic Biol Med. 88 (Pt A): 59–62. doi:10.1016/j.freeradbiomed.2015.05.044. PMID 26086616.
- ↑ Valenzise M, Alessi L, Bruno E, Cama V, Costanzo D, Genovese C; et al. (2016). "APECED syndrome in childhood: clinical spectrum is enlarging". Minerva Pediatr. 68 (3): 226–9. PMID 25502918.
- ↑ Wilcox C, Turner J, Green J (2014). "Systematic review: the management of chronic diarrhoea due to bile acid malabsorption". Aliment Pharmacol Ther. 39 (9): 923–39. doi:10.1111/apt.12684. PMID 24602022.
- ↑ "Weighing a Pill For Weight Loss". Washington Post. Retrieved 2007-07-06.
While the Food and Drug Administration (FDA) still must approve the switch, the agency often follows the advice of its experts. If it does, Orlistat (xenical) -- currently sold only by prescription -- could be available over-the-counter (OTC) later this year. But it's important to know that the weight loss that's typical for users of the drug -- 5 to 10 percent of total weight -- will be less than many dieters expect. And many consumers may be put off by the drug's significant gastrointestinal side effects, including flatulence, diarrhea and anal leakage.
- ↑ "Frito-Lay Study: Olestra Causes "Anal Oil Leakage"". Center for Science in the Public Interest. Thursday, February 13, 1997. Retrieved 2007-07-07.
The Frito-Lay report states: "The anal oil leakage symptoms were observed in this study (3 to 9% incidence range above background), as well as other changes in elimination. ... Underwear spotting was statistically significant in one of two low level consumer groups at a 5% incidence above background." Despite those problems, the authors of the report concluded that olestra-containing snacks "should have a high potential for acceptance in the marketplace."
Check date values in:|date=
(help) - ↑ "The Word Is 'Leakage'. Accidents may happen with a new OTC diet drug". Newsweek. June 25, 2007. Retrieved 2007-06-21.
GlaxoSmithKline has a tip for people who decide to try Alli, the over-the-counter weight-loss drug it is launching with a multimillion-dollar advertising blitz—keep an extra pair of pants handy. That's because Alli, a lower-dose version of the prescription drug Xenical, could (cue the late-night talk-show hosts) make you soil your pants. But while Alli's most troublesome side effect, anal leakage, is sure to be good for a few laughs, millions of people who are desperate to take off weight may still decide the threat of an accident is worth it.
- ↑ "Reported medical side-effects of Olestra according to Procter and Gamble studies". Center for Science in the Public Interest. Retrieved 2007-06-21.
Olestra sometimes causes underwear staining associated with "anal leakage." Olestra sometimes causes underwear staining. That phenomenon may be caused most commonly by greasy, hard-to-wipe-off fecal matter, but occasionally also from anal leakage (leakage of liquid olestra through the anal sphincter).